News & Updates
Filter by Specialty:
Semaglutide makes STRIDEs in peripheral artery disease
Patients with symptomatic peripheral artery disease and type 2 diabetes see notable improvements in their walking capacity and quality of life with once-weekly semaglutide injections in the phase 3b STRIDE study.
Semaglutide makes STRIDEs in peripheral artery disease
09 Apr 2025
Endocrinologic dysfunction common among CNS infection survivors
Children who survived central nervous system (CNS) infections experience many endocrinologic imbalances, according to a study. Of these infections, meningitis poses the highest risk of subsequent endocrinopathies, particularly short stature.
Endocrinologic dysfunction common among CNS infection survivors
02 Apr 2025
Tirzepatide lowers HbA1c, body weight in adults with T2D
Treatment with tirzepatide once weekly results in significant decreases in glycated haemoglobin A1c (HbA1c) and body weight (BW), regardless of antiglutamic acid decarboxylase autoantibodies (GADA) status in adults with type 2 diabetes (T2D), according to a post hoc analysis of SURPASS.
Tirzepatide lowers HbA1c, body weight in adults with T2D
01 Apr 2025
Poor glycaemic status singled out for dementia risk in T2D
Poor glycaemic status may predispose individuals with type 2 diabetes (T2D) to dementia, with the risk especially high in those experiencing significant fluctuations in glycaemic levels, as reported in a retrospective cohort study.